Matthew W. Foehr
2015 - Ligand Pharmaceuticals
In 2015, Matthew W. Foehr earned a total compensation of $3.4M as President and Chief Operating Officer at Ligand Pharmaceuticals, a 17% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $196,000 |
|---|---|
| Option Awards | $1,356,995 |
| Salary | $410,472 |
| Stock Awards | $1,250,322 |
| Other | $143,501 |
| Total | $3,357,290 |
Foehr received $1.4M in option awards, accounting for 40% of the total pay in 2015.
Foehr also received $196K in non-equity incentive plan, $410.5K in salary, $1.3M in stock awards and $143.5K in other compensation.
Rankings
In 2015, Matthew W. Foehr's compensation ranked 2,732nd out of 13,638 executives tracked by ExecPay. In other words, Foehr earned more than 80.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,732 out of 13,638 | 80th |
Division Manufacturing | 963 out of 5,187 | 81st |
Major group Chemicals And Allied Products | 351 out of 1,857 | 81st |
Industry group Drugs | 275 out of 1,531 | 82nd |
Industry Pharmaceutical Preparations | 217 out of 1,179 | 82nd |
Source: SEC filing on April 14, 2017.
Foehr's colleagues
We found five more compensation records of executives who worked with Matthew W. Foehr at Ligand Pharmaceuticals in 2015.
2015
John Higgins
Ligand Pharmaceuticals
Chief Executive Officer
2015
Matthew Korenberg
Ligand Pharmaceuticals
Chief Financial Officer
2015
Nishan de Silva
Ligand Pharmaceuticals
Chief Financial Officer
2015
Charles Berkman
Ligand Pharmaceuticals
General Counsel
2015
Melanie Herman
Ligand Pharmaceuticals